Wearable biofeedback devices for remote rehabilitation of elderly patients with arthritis and fibromyalgia: a randomized controlled trial protocol

Arthritis and fibromyalgia are prevalent chronic conditions among elderly individuals, significantly impairing mobility, pain management, and overall well-being. Traditional physiotherapy is often inaccessible due to mobility constraints, high costs, and limited healthcare facilities, particularly in resource-limited urban centers like Karachi, Pakistan. Wearable biofeedback devices provide real-time physiological monitoring and feedback, enabling home-based, personalized rehabilitation. This protocol describes a randomized controlled trial (RCT) designed to evaluate the effectiveness of wearable biofeedback devices in improving pain management, functional mobility, and rehabilitation outcomes among elderly patients with arthritis and fibromyalgia. This single-blind, parallel-group randomized controlled trial will enroll 120 adults aged 60–80 years with arthritis or fibromyalgia (60 per group). Over 8 weeks, the intervention group will receive wearable biofeedback-assisted home physiotherapy with weekly remote consultations, while controls will receive standard home physiotherapy with biweekly consultations. Assessments will occur at baseline, week 4, and week 8. The primary outcome will be VAS pain intensity at week 8, adjusted for baseline values. Secondary outcomes will include functional mobility, range of motion, heart rate variability, exercise adherence, psychological well-being, quality of life, device usability, and satisfaction. Longitudinal data will be analyzed using mixed-effects models following the intention-to-treat principle. Expected Results This study will generate evidence on the feasibility and potential benefits of wearable-assisted rehabilitation for elderly populations. The trial will also provide insight into cost-effectiveness, usability, and accessibility in resource-constrained contexts. This protocol will address the impact of wearable biofeedback in remote physiotherapy, aiming to evaluate its effectiveness in enhancing pain management, functional recovery, and accessibility for elderly individuals with arthritis and fibromyalgia. The findings are expected to inform future implementation of technology-assisted rehabilitation in resource-limited settings. ClinicalTrials.gov NCT06960330. Registration on April 19, 2025. Version Date: 21 July 2026.

Authors

Institutions

Publication Details

Journal
Trials
Published
2026-11-09
DOI
https://doi.org/10.1186/s13063-026-10073-2
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Wearable biofeedback devices for remote rehabilitation of elderly patients with arthritis and fibromyalgia: a randomized controlled trial protocol

Shamoon Noushad, Basit Ansari, Sadaf Ahmed, Muhammad Jabbar
Trials
Mobile Health and mHealth Applications
article

Wearable biofeedback devices for remote rehabilitation of elderly patients with arthritis and fibromyalgia: a randomized controlled trial protocol

Shamoon Noushad, Basit Ansari, Sadaf Ahmed, Muhammad Jabbar
article en

Abstract

Arthritis and fibromyalgia are prevalent chronic conditions among elderly individuals, significantly impairing mobility, pain management, and overall well-being. Traditional physiotherapy is often inaccessible due to mobility constraints, high costs, and limited healthcare facilities, particularly in resource-limited urban centers like Karachi, Pakistan. Wearable biofeedback devices provide real-time physiological monitoring and feedback, enabling home-based, personalized rehabilitation. This protocol describes a randomized controlled trial (RCT) designed to evaluate the effectiveness of wearable biofeedback devices in improving pain management, functional mobility, and rehabilitation outcomes among elderly patients with arthritis and fibromyalgia. This single-blind, parallel-group randomized controlled trial will enroll 120 adults aged 60–80 years with arthritis or fibromyalgia (60 per group). Over 8 weeks, the intervention group will receive wearable biofeedback-assisted home physiotherapy with weekly remote consultations, while controls will receive standard home physiotherapy with biweekly consultations. Assessments will occur at baseline, week 4, and week 8. The primary outcome will be VAS pain intensity at week 8, adjusted for baseline values. Secondary outcomes will include functional mobility, range of motion, heart rate variability, exercise adherence, psychological well-being, quality of life, device usability, and satisfaction. Longitudinal data will be analyzed using mixed-effects models following the intention-to-treat principle. Expected Results This study will generate evidence on the feasibility and potential benefits of wearable-assisted rehabilitation for elderly populations. The trial will also provide insight into cost-effectiveness, usability, and accessibility in resource-constrained contexts. This protocol will address the impact of wearable biofeedback in remote physiotherapy, aiming to evaluate its effectiveness in enhancing pain management, functional recovery, and accessibility for elderly individuals with arthritis and fibromyalgia. The findings are expected to inform future implementation of technology-assisted rehabilitation in resource-limited settings. ClinicalTrials.gov NCT06960330. Registration on April 19, 2025. Version Date: 21 July 2026.

Trials
University of Karachi (PK)
Good health and well-being
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon